Crosscheck

Your medical. Crosschecked.

Check another medication

Heart

Ranolazine

Angina medication
Other names: Ranexa

FAA guidance

Do not issue.

Examiner

Do not issue: the examiner cannot issue a certificate

FAA label

DO NOT ISSUE

Source: FAA, DO NOT ISSUE – DO NOT FLY Medications and general No Fly wait times. FAA date 30 September 2026. Checked by Crosscheck 14 October 2026

The FAA lists ranolazine on its Do Not Issue list, where the FAA's table says the examiner should defer the exam and says do not issue a medical certificate.

Track your medications
Show the FAA's words: ranolazineThe official FAA wording: one passage, each with its document and dateOpen
FAA, DO NOT ISSUE – DO NOT FLY Medications and general No Fly wait times · FAA date 30 September 2026
DO NOT ISSUE (DNI) MEDICATIONS
If the applicant is taking any of the following medications, AMEs should DEFER the exam. DO NOT issue a medical certificate to applicants who are using any of the following drug classes or medications for any condition:
ANGINA MEDICATIONS
nitrates (nitroglycerin, isosorbide dinitrate [Imdur])
ranolazine (Ranexa)
Sources and dates: ranolazineOne FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.